A case of hepatitis related to etretinate therapy and hepatitis B vaccine

Dermatologica. 1991;182(2):119-20. doi: 10.1159/000247758.

Abstract

The case of a 41-year-old male patient is described who developed acute reversible hepatitis related to etretinate therapy. During the course of etretinate he received 2 doses of hepatitis B vaccine; this and his HLA typing A1, A2, Bw57, Cw6 may have predisposed him to develop this reaction.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / immunology
  • Etretinate / adverse effects*
  • HLA Antigens / analysis
  • Hepatitis B Vaccines
  • Humans
  • Male
  • Psoriasis / drug therapy
  • Risk Factors
  • Viral Hepatitis Vaccines / administration & dosage
  • Viral Hepatitis Vaccines / adverse effects*

Substances

  • HLA Antigens
  • Hepatitis B Vaccines
  • Viral Hepatitis Vaccines
  • Etretinate